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Background
The importance of events in acute HIV-1 infection (AHI)
in determining the subsequent disease course prompts a
need to understand the virus-immune system interactions
in this phase of infection that impact on concurrent and
ensuing viral replication and pathogenesis. The speed with
which innate responses can be mobilized following patho-
gen exposure suggests they may play critical roles in AHI.
We sought to characterise the innate responses activated
during AHI and identify components of the response that
contribute to control of viremia or conversely promote
immune activation and virus replication.
Materials and methods
Peripheral blood samples were cryopreserved at serial
timepoints from subjects acutely infected with HIV.
The dynamics of systemic up-regulation of cytokines/
chemokines were analysed using Luminex multiplex
assays and ELISAs, and activation of innate cell subsets
was evaluated by multiparameter flow cytometry.
Spearman correlation analyses and multiple regression
modelling were employed to determine relationships
between innate variables and assess their impact on
viral control.
Primary HIV isolates were derived from plasma cryo-
preserved at timepoints in acute and chronic infection
and their sensitivity to control by IFN alpha and IFN
beta was evaluated using in vitro assays. The IFN sensi-
tivity of viruses generated from infectious molecular
clones (IMCs) corresponding to deduced founder and
paired 6-month virus sequences was also assessed.
Results
The increase in viremia in AHI was associated with rapid
activation of systemic innate responses, evidenced by a
reduction in the circulating dendritic cell frequency, ele-
vations in plasma levels of type 1 interferon (IFN) and
other cytokines and chemokines, and natural killer (NK)
cell activation and proliferation. Some components of the
innate response, e.g. strong NK cell responses, correlated
with establishment of lower set-point viral loads, whereas
others, such as inflammatory cytokine production, corre-
lated with establishment of higher set-point viral loads.
However multiple regression modelling illustrated that
the association between any one component of the innate
response and set-point viremia was confounded by other
interlinked innate variables.
To seek evidence that type 1 IFN exerts selective pres-
sure on HIV replication during the establishment of
infection, the IFN-resistance of HIV isolates derived from
AHI subjects and founder virus IMCs was compared to
that of virus isolates/IMCs generated from the same sub-
jects later in infection. Founder viruses were found to be
significantly more IFN-resistant than matched viruses
present in the same subjects at later times post-infection,
suggesting that type I IFN plays an important role in HIV
control during the initial stages of infection and may
drive selection for IFN-resistant founder viruses from the
transmitted virus pool.
Conclusions
Identification of type 1 IFN-mediated antiviral activity
and NK effector activity as mechanisms that contribute
to HIV-1 control during the initial stages of infection
could enable harnessing of these activities to complement1Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
Full list of author information is available at the end of the article
Borrow et al. Retrovirology 2013, 10(Suppl 1):O33
http://www.retrovirology.com/content/10/S1/O33
© 2013 Borrow et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
the protection afforded by vaccine-elicited adaptive
responses.
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